Konturek S J, Kwiecień N, Dobrzańska M, Gawronek J, Oleksy J, Coy D H
Scand J Gastroenterol. 1983 Jul;18(5):679-84. doi: 10.3109/00365528309181657.
Pancreatic secretory responses to modified sham-feeding (MSF) and secretin (1 U/kg-h) infusion were examined in eight healthy subjects with and without administration of the stable enkephalin analogue (Ala-Enk) and/or naloxone. MSF produced a clear increase in pancreatic protein output, reaching about 45% of caerulein (0.5 microgram/kg-h) maximal output. This response was significantly reduced by Ala-enk (20 micrograms/kg-h) but was not affected by naloxone (40 micrograms/kg-h). Ala-Enk given during a well-sustained plateau of pancreatic response to secretin also significantly suppressed both bicarbonate and protein; the effect was not influenced by the addition of naloxone. Naloxone alone without Ala-Enk did not affect basal or stimulated pancreatic secretion. We conclude that enkephalin inhibits pancreatic secretion induced by vagal or secretin stimulation, and this inhibition does not seem to be mediated by opiate receptors of the mu type, since naloxone was ineffective in the prevention of this effect.
在8名健康受试者中,研究了在给予和不给予稳定脑啡肽类似物(Ala-Enk)和/或纳洛酮的情况下,胰腺对改良假饲(MSF)和促胰液素(1 U/kg-h)输注的分泌反应。MSF使胰腺蛋白质输出明显增加,达到蛙皮素(0.5微克/千克-h)最大输出量的约45%。Ala-脑啡肽(20微克/千克-h)可显著降低这种反应,但纳洛酮(40微克/千克-h)对其无影响。在胰腺对促胰液素反应持续良好的平台期给予Ala-Enk,也可显著抑制碳酸氢盐和蛋白质的分泌;该效应不受纳洛酮添加的影响。单独使用纳洛酮而不使用Ala-Enk不影响基础或刺激后的胰腺分泌。我们得出结论,脑啡肽抑制迷走神经或促胰液素刺激诱导的胰腺分泌,并且这种抑制似乎不是由μ型阿片受体介导的,因为纳洛酮在预防这种效应方面无效。